Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

23.85INR
10:22am GMT
Change (% chg)

Rs-0.10 (-0.42%)
Prev Close
Rs23.95
Open
Rs24.25
Day's High
Rs24.35
Day's Low
Rs23.65
Volume
760,853
Avg. Vol
1,173,627
52-wk High
Rs40.60
52-wk Low
Rs21.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 2,483.65 0.600
Sep 2,690.41 0.479
Jun 2,352.53 0.583
FY 2018 Mar '18 1,993.94 -0.168
Dec 2,184.34 0.410
Sep 2,738.09 0.230
Jun 2,210.56 0.333
FY 2017 Mar '17 1,847.49 -0.152
Dec 2,152.39 0.243
Sep 1,804.26 0.017
Jun 1,867.47 0.110
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 16.03 57.04 57.42
P/E High - Last 5 Yrs. 218.35 49.14 55.59
P/E Low - Last 5 Yrs. 12.78 28.15 28.99
Beta 1.92 0.94 0.93
Price to Sales (TTM) 1.03 6.64 8.70
Price to Book (MRQ) -- 4.11 4.56
Price to Tangible Book (MRQ) -- 6.62 7.71
Price to Cash Flow (TTM) 11.29 39.98 39.68
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 0.21 1.67 1.52
Dividend Yield - 5 Year Avg 0.21 1.45 1.34
Dividend 5 Year Growth Rate -- -9.94 -7.25
Payout Ratio(TTM) 4.04 44.69 41.69

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 13.70 27.98 26.57
Sales (TTM) vs TTM 1 Yr. Ago 6.01 4.25 7.00
Sales - 5 Yr. Growth Rate 15.79 10.62 11.68
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.48 122.30 97.74
EPS (TTM) vs TTM 1 Yr. Ago 81.96 -- --
EPS - 5 Yr. Growth Rate -7.54 6.22 7.74
Capital Spending - 5 Yr. Growth Rate 43.38 8.68 9.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.53
Current Ratio (MRQ) -- 3.50 3.47
LT Debt to Equity (MRQ) -- 13.01 13.86
Total Debt to Equity (MRQ) -- 15.71 17.53
Interest Coverage (TTM) 6.25 44.89 39.94

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 49.43 52.67 51.12
Gross Margin - 5 Yr. Avg. 38.28 50.30 51.16
EBITD Margin (TTM) 11.85 -- --
EBITD - 5 Yr. Avg 13.34 17.19 16.00
Operating Margin (TTM) 9.47 12.52 5.27
Operating Margin - 5 Yr. Avg. 10.42 13.40 11.30
Pre-Tax Margin (TTM) 8.61 11.91 4.74
Pre-Tax Margin - 5 Yr. Avg. 10.35 19.50 16.37
Net Profit Margin (TTM) 6.73 8.24 0.92
Net Profit Margin - 5 Yr. Avg. 7.89 14.53 11.48
Effective Tax Rate (TTM) 21.78 22.65 22.80
Effective Tax Rate - 5 Yr. Avg. 23.77 23.45 23.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 12,128,060 876,841,310 752,055,124
Net Income/Employee (TTM) 816,611 101,601,843 87,168,920
Receivable Turnover (TTM) -- 5.09 4.95
Inventory Turnover (TTM) -- 2.63 3.70
Asset Turnover (TTM) -- 0.86 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.30 9.86
Return on Assets - 5 Yr. Avg. 9.85 11.51 10.90
Return on Investment (TTM) -- 12.61 12.18
Return on Investment - 5 Yr. Avg. 18.05 14.87 14.08
Return on Equity (TTM) -- 13.59 13.28
Return on Equity - 5 Yr. Avg. 18.25 16.03 15.50
  1 Year 3 Year 5 Year
Sales % 18.97 4.64 15.79
EPS (TTM) % 272.68 -32.97 -7.54
Dividend % 0.00 -25.31 --
Note: Units in Millions of US Dollars

Performance for Marksans Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -4.22 99 50
13 Week -14.16 -19.47 68 19
26 Week -27.09 -29.99 99 72
52 Week -23.85 -34.35 99 61
YTD -14.00 -17.96 73 27
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.39%
# of Holders: 9
Total Shares Held: 13,866,619
3 Mo. Net Change: -106,828
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 4
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.